Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

被引:1
|
作者
Wu, Che-Yuan [1 ,2 ]
Shah, Baiju R. [3 ,4 ,5 ]
Sharma, Abhinav [6 ,7 ]
Sheng, Yiru [3 ]
Liu, Peter P. [8 ]
Kopp, Alexander [3 ]
Saskin, Refik [3 ]
Edwards, Jodi D. [8 ,9 ,10 ]
Swardfager, Walter [1 ,2 ,11 ]
机构
[1] Univ Toronto, Dept Pharmacol & Toxicol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[2] Sunnybrook Res Inst, Dr Sandra Black Ctr Brain Resilience & Recovery, Hurvitz Brain Sci Program, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Med, Div Endocrinol, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] McGill Univ, Hlth Ctr, Div Cardiol, Montreal, PQ, Canada
[7] McGill Univ, Hlth Ctr, DREAM CV Lab, Montreal, PQ, Canada
[8] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[9] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[10] ICES UOttawa, Ottawa, ON, Canada
[11] KITE Univ Hlth Network Toronto Rehabil Inst, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Acute heart failure; Diabetes; SGLT2; inhibitor; Pharmacoepidemiology; IMPACT; RISK;
D O I
10.1002/ejhf.3464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sodium-glucose cotransporter 2 (SGLT2) inhibitors in acute heart failure. image
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [31] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections A Population-Based Cohort Study
    Dave, Chintan V.
    Schneeweiss, Sebastian
    Kim, Dae
    Fralick, Michael
    Tong, Angela
    Patorno, Elisabetta
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (04) : 248 - +
  • [32] Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular and Renal Outcomes in Heart Failure Patients With Type 2 Diabetes: A Literature Review
    Llerena-Velastegui, Jordan
    Santamaria-Lasso, Melisa
    Mejia-Mora, Melany
    Granda-Munoz, Andrea
    Trujillo-Delgado, Martin
    Hurtado-Alzate, Claudia
    de Jesus, Ana Clara Fonseca Souza
    Coelho, Pedro Moraes
    Baldelomar-Ortiz, Jurgen
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (09): : 398 - 410
  • [33] Early Initiation of Sodium-Glucose Cotransporter 2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta-Analysis
    Cherbi, Miloud
    Lairez, Olivier
    Baudry, Guillaume
    Gautier, Paul
    Roubille, Francois
    Delmas, Clement
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (08):
  • [34] Sodium-glucose co-transporter-2 inhibitors and susceptibility toCOVID-19: A population-based retrospective cohort study
    Sainsbury, Christopher
    Wang, Jingya
    Gokhale, Krishna
    Acosta-Mena, Dionisio
    Dhalla, Samir
    Byne, Nathan
    Chandan, Joht Singh
    Anand, Astha
    Cooper, Jennifer
    Okoth, Kelvin
    Subramanian, Anuradhaa
    Bangash, Mansoor N.
    Taverner, Thomas
    Hanif, Wasim
    Ghosh, Sandip
    Narendran, Parth
    Cheng, Kar K.
    Marshall, Tom
    Gkoutos, Georgios
    Toulis, Konstantinos
    Thomas, Neil
    Tahrani, Abd
    Adderley, Nicola J.
    Haroon, Shamil
    Nirantharakumar, Krishnarajah
    DIABETES OBESITY & METABOLISM, 2021, 23 (01) : 263 - 269
  • [35] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population-Based Investigation
    Kwon, Osung
    Myong, Jun-Pyo
    Lee, Yunhee
    Choi, Yeon-Jik
    Yi, Jeong Eun
    Seo, Suk Min
    Jang, Sung-Won
    Kim, Pum Joon
    Lee, Jung-Min
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [36] Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
    Storgaard, Heidi
    Bagger, Jonatan I.
    Knop, Filip K.
    Vilsboll, Tina
    Rungby, Jorgen
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (02) : 168 - 170
  • [37] Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom
    Alkabbani, Wajd
    Shah, Baiju R.
    Zongo, Arsene
    Eurich, Dean T.
    Alsabbagh, Mhd Wasem
    Gamble, John-Michael
    DIABETES OBESITY & METABOLISM, 2023, 25 (12) : 3490 - 3500
  • [38] In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
    Arshad, Muhammad Sameer
    Jamil, Adeena
    Greene, Stephen J.
    Van Spall, Harriette G. C.
    Fonarow, Gregg C.
    Butler, Javed
    Khan, Muhammad Shahzeb
    HEART FAILURE REVIEWS, 2025, 30 (01) : 89 - 101
  • [39] Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study
    Chang, Ting-Yung
    Lu, Chi-Ting
    Huang, Hsin-Lei
    Chou, Ruey-Hsing
    Chang, Chun-Chin
    Liu, Chung-Te
    Huang, Po-Hsun
    Lin, Shing-Jong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [40] Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
    Kurczynski, Dominik
    Hudzik, Bartosz
    Jagosz, Marta
    Zabierowski, Jan
    Nowak, Jolanta
    Tomasik, Andrzej
    Badzinski, Arkadiusz
    Rozentryt, Piotr
    Gasior, Mariusz
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (07)